Lantern Pharma (LTRN) Earnings Date & Reports

A.I. Advisor

published Earnings

LTRN is expected to report earnings to rise 23.91% to -56 cents per share on October 30

Lantern Pharma LTRN Stock Earnings Reports

Q3'24

Est.

$-0.57

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.08

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.19

The last earnings report on August 08 showed earnings per share of -46 cents, beating the estimate of -55 cents. With 92.47K shares outstanding, the current market capitalization sits at 37.25M.

View a ticker or compare two or three

Compare

LTRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LTRN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1920 McKinney Avenue

Phone

+1 972 277-1136

Employees

Web

https://www.lanternpharma.com